Edesa Biotech (EDSA) Gross Profit (2013 - 2020)

Edesa Biotech (EDSA) posted Gross Profit of -$1814.0 for Q3 2020, down 101.67% sequentially from $108513.0 in Q2 2020.

Edesa Biotech (EDSA) Gross Profit (2013 - 2020) Analysis & Trends

Edesa Biotech has reported Gross Profit for 8 years, with the latest figure at -$1814.0 in Q3 2020.

Quarterly Gross Profit changed N/A year-over-year to -$1814.0 in Q3 2020, while the trailing twelve-month figure through Jun 2021 was -$1814.0 (down 100.58% YoY) and the FY2020 annual result came in at $311200.0, up 0.52% from the prior year.
Gross Profit retreated to -$1814.0 in Q3 2020 per EDSA's latest filing, from $108513.0 in the prior quarter.
Over five years, Gross Profit peaked at $644348.0 in Q3 2016 and troughed at -$232255.0 in Q3 2017.
A 5-year average of $58731.0 and a median of $58.5 in 2017 frame the typical range for Gross Profit.
The sharpest annual moves came in 2018 and 2020: Gross Profit tumbled 2608.09% in 2018, then jumped 21602.6% in 2020.
Over 5 years, Gross Profit stood at $57021.0 in 2016, then tumbled by 236.03% to -$77563.0 in 2017, then soared by 75.15% to -$19277.0 in 2018, then soared by 639.62% to $104022.0 in 2019, then tumbled by 101.74% to -$1814.0 in 2020.
According to Business Quant data, Gross Profit over the past three periods registered -$1814.0, $108513.0, and $100479.0 for Q3 2020, Q2 2020, and Q1 2020 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Edesa Biotech	40.44 Mn	40.44 Mn	-

Download Data